Physician profile
Jonathan Menachem
NPI 1245556554
$78,594.08
in general payments reported to CMS, 2019-2025
8 companies · $2,255 in 2025
The $2,255 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,235 · 2020: $7,015 · 2021: $13K · 2022: $18K · 2023: $21K · 2024: $11K · 2025: $2,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Travel and Lodging: $5,486 · Food and Beverage: $3,515 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,118.50 |
| Travel and Lodging | $5,486.21 |
| Food and Beverage | $3,515.43 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $56,180.19 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Ensite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9,476.07 | 2020-2022 | |
| Medtronic Vascular, INC. | $5,749.52 | 2019-2020 | |
| Abiomed | $5,085.86 | 2019-2023 | Impella |
| Medtronic, INC. | $1,800.00 | 2021 | |
| Impulse Dynamics (USA) INC. | $212.14 | 2021 | |
| Cvrx, INC. | $74.40 | 2024 | Barostim Neo System |
| Heartflow, INC. | $15.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Menachem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.